Carbamazepine (Tegretol)
Order Name
TEGRETOL
Test Number: 4004800
Revision Date 04/30/2021
Test Number: 4004800
Revision Date 04/30/2021
| Test Name | Methodology | LOINC Code |
|---|---|---|
|
Carbamazepine (Tegretol)
|
Enzyme Immunoassay | 3432-2 |
| SPECIMEN REQUIREMENTS | ||||
|---|---|---|---|---|
| Specimen | Specimen Volume (min) | Specimen Type | Specimen Container | Transport Environment |
| Preferred | 1 mL (0.5) | Plasma | Lithium Heparin PST (Light Green Top) | Refrigerated |
| Alternate 1 | 1 mL (0.5) | Serum | Clot Activator SST | Refrigerated |
| Instructions | Draw before next dose. Stability: Ambient 2 days, Refrigerated 7 days, Frozen 1 month |
|||
| GENERAL INFORMATION | |
|---|---|
| Testing Schedule | Daily |
| Expected TAT | 1-2 days |
| Clinical Use | Useful for monitoring patients with Tegretol toxicity. |
| Notes | Carbamazepine and its metabolite (10,11- Carbamazepine epoxide) are widely used for control of generalized tonic-clonic, partial-onset, complex and mixed seizure disorders. The metabolism of carbamazepine in epileptic patients has several different pathways that can be altered when the patient is co-medicated with other anticonvulsants and, therefore, it's therapeutic level should be monitored along with its metabolite in their free and protein bound states. |
| CPT Code(s) | 80156 |
| Lab Section | Chemistry |